Inflammatory Bowel Diseases (IBD)

Latest News

Fecal Transplantation Associated With Improvements in IBS Symptoms

By

Emily Pond

Although further study is required, pilot study results suggest that FMT may be a viable option for patients with IBS with significant bloating.

Ortikos Now Available for Mild to Moderate Crohn Disease

By

Brian Park, PharmD

Ortikos, an anti-inflammatory corticosteroid, is approved as a once-daily treatment for mild to moderate active Crohn disease and for maintenance of clinical remission.

Discontinuation of Anti-TNF Agents More Likely in Patients With IBD Plus Anxiety, Mood Disorders

By

Brandon May

A team of investigators assessed the impact of anxiety and mood disorders on treatment with anti-tumor necrosis factor agents in individuals with inflammatory bowel disease.

Are There Sufficient Data to Confirm a Protective Role for Anti-TNF in COVID-19?

By

Jessica Nye, PhD

Authors of a letter to the editor raised questions about research that reported a protective role of anti-tumor necrosis factor therapy against COVID-19 among patients with inflammatory bowel disease.

Inflammatory Bowel Disease Associated With Higher Bacterial, Viral Meningitis Risk

By

Brandon May

Study finds that patients with IBD and 1 or more comorbidities are at increased risk for viral or bacterial meningitis.

Efficacy of Cannabinoids in Treating IBD Examined

By

Cassandra Pardini, PharmD

Significant improvements in both clinical symptoms (ie, abdominal pain, general well-being, nausea, diarrhea, and decreased appetite) as well as QoL scores were observed with cannabinoids.

Assessing Symptoms, Blood, Stool Markers Best for Identifying Pediatric IBD

For pediatric patients with nonbloody diarrhea, evaluating symptoms plus blood and stool markers is the optimal test strategy for predicting inflammatory bowel disease.

Lower Risk for Relapse in Patients With Clinical and Endoscopic Remission of Ulcerative Colitis

By

Jessica Nye, PhD

A team of investigators conducted a systematic review to estimate the risk of relapse in patients with ulcerative colitis in remission.

Automated Ulcer Severity Grading Model Accurate in Crohn Disease

By

Jessica Nye, PhD

A team of investigators assessed the accuracy of a machine learning model in grading the severity of ulcers in patients with Crohn disease.

FDA Approves Adalimumab Biosimilar for IBD

By

Brian Park, PharmD

The Food and Drug Administration (FDA) has approved Hulio® (adalimumab-fkjp; Mylan), a biosimilar to Humira® (adalimumab; AbbVie).

A Bidirectional Relationship Between Atopic Dermatitis and IBD?

By

Brandon May

Support is given for an association between atopic dermatitis and inflammatory bowel disease, and underscores the value of a multidisciplinary treatment approach.

Risk for Severe COVID-19 Not Elevated in Patients with Inflammatory Bowel Disease

By

Jessica Nye, PhD

Patients with inflammatory bowel disease had a similar risk for and outcomes from coronavirus disease 2019 as those in the general population.

Vitamin D May Reduce Immune Checkpoint Inhibitor–Related Colitis

By

Jonathan Goodman, MPhil

Vitamin D may be used to reduce the risk of immune checkpoint inhibitor-related colitis, as well as ulcerative colitis and graft-vs-host disease.

Standard Definition White Light Endoscopy Is an Inferior Surveillance Modality for Ulcerative Colitis

By

Jessica Nye, PhD

The majority of endoscopic modalities for ulcerative colitis (UC) neoplasia surveillance were similarly effective, but white light standard definition (WL SD) was the least so.

Psoriasis, Psoriatic Arthritis Associated With Inflammatory Bowel Disease and Other Gastrointestinal Illnesses

By

Meghna Rao

Researchers evaluated the association of psoriasis and psoriatic arthritis with inflammatory bowel disease and other gastrointestinal illnesses.

Inflammatory Bowel Disease Linked to Subsequent Dementia

Inflammatory bowel disease is associated with an increased risk for developing dementia.

Guideline Issued on the Use of Probiotics for Managing GI Disorders

By

Cassandra Pardini, PharmD

Probiotics should only be recommended for specific patient populations since there is not enough evidence to support their use in the majority of digestive conditions, according to new clinical guidelines released by the American Gastroenterological Association (AGA) and recently published in Gastroenterology.

Perianal Fistulizing Complications Preventable in Crohn Disease

Steroid-sparing therapy may reduce risk for PFCs in young patients with Crohn disease

Fecal Calprotectin Level After Bowel Resection is Predictive of Endoscopic Postoperative Recurrence in Crohn Disease

By

Dibash Kumar Das, PhD

Variation in fecal calprotectin levels after ileocolonic resection is an accurate predictor of early endoscopic POR in patients with Crohn’s disease.

Abbreviated Inflammatory Bowel Disease Disability Index Deemed Valid

By

Jessica Nye, PhD

According to results from a large cohort validation study, IBD-Disk was reported to be both viable and reliable.